Multitasking exercises improve arm strength
- Trial ID
- NCT07536542
- Official Title
- Effects of Dual-Task Training on Upper Extremity Function and Muscle Thickness in Parkinson's Disease
- Goal
- Multitasking exercises improve arm strength
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Ankara University
- Study Type
- INTERVENTIONAL
- Enrollment
- 38 participants
- Conditions
- Parkinson Disease (PD)
- Interventions
- Dual-Task Training
Summary For Families
The goal is to improve arm and hand function and increase muscle thickness in people with Parkinson's by reducing the drop in performance that happens when you try to move while also doing a thinking task. The approach is dual-task training, where repetitive upper-limb exercises are practiced at the same time as a cognitive or secondary motor task to retrain attention, timing, muscle activation, and strength; it is a non-drug rehabilitation method and does not directly interact with levodopa, and participants must have had no medication changes in the past 6 months. Participants should be aged 40 to 65 with idiopathic Parkinson's at Hoehn and Yahr stage 2 to 3, able to follow instructions (MoCA ≥21), and free of major upper limb injuries, atypical parkinsonism, severe sensory or psychiatric problems that would prevent regular participation.
Locations
- Hacettepe University, Ankara, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Dual-Task Training. The goal is to improve arm and hand function and increase muscle thickness in people with Parkinson's by reducing the drop in performance that happens when you try to move while also doing a thinking task. The approach is dual-task training, where repetitive upper-limb exercises are practiced at the same time as a cognitive or secondary motor task to retrain attention, timing, muscle activation, and strength; it is a non-drug rehabilitation method and does not directly interact with levodopa, and participants must have had no medication changes in the past 6 months. Participants should be aged 40 to 65 with idiopathic Parkinson's at Hoehn and Yahr stage 2 to 3, able to follow instructions (MoCA ≥21), and free of major upper limb injuries, atypical parkinsonism, severe sensory or psychiatric problems that would prevent regular participation.
- Who can participate?
- Participants must be between 40 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.